Bmi‑1 induces radioresistance by suppressing senescence in human U87 glioma cells

Ye,Lan; Wang,Cuihong; Yu,Guanying; Jiang,Yuhua; Sun,Dianshui; Zhang,Zaiyun; Yu,Xiaoming; Li,Xiaomei; Wei,Wei; Liu,Ping; Cheng,Jian; Du,Bin; Hu,Likuan

doi:10.3892/ol.2014.2606

Bmi‑1 induces radioresistance by suppressing senescence in human U87 glioma cells

Authors:
- Lan Ye
- Cuihong Wang
- Guanying Yu
- Yuhua Jiang
- Dianshui Sun
- Zaiyun Zhang
- Xiaoming Yu
- Xiaomei Li
- Wei Wei
- Ping Liu
- Jian Cheng
- Bin Du
- Likuan Hu
View Affiliations

Affiliations: Cancer Center, The Second Hospital of Shandong University, Jinan, Shandong 250033, P.R. China, Jinan Central Hospital, Jinan, Shandong 250014, P.R. China, Department of Radiotherapy, Qilu Hospital, Shandong University, Jinan, Shandong 250012, P.R. China
Published online on: October 10, 2014 https://doi.org/10.3892/ol.2014.2606
Pages: 2601-2606

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Radiotherapy is the main locoregional control modality for a number of types of malignant tumors, including glioblastoma. However, radiotherapy fails to prevent recurrence in numerous patients due to the intrinsic radioresistance of cancer cells. Cell senescence is significant in tumor suppressor mechanisms and is closely associated with the radioresistance of cancer cells. Bmi‑1 has been proposed to be an oncogene that can induce anti‑senescence in tumor cells. The present study investigated the response of U87 glioma cells to radiation exposure and the role of Bmi‑1 in the response following radiotherapy. Cell apoptosis and cell cycle distribution were assessed using flow cytometry, and a SA‑β‑Gal stain was used to observe the senescence ratio of U87 cells following radiation. The expression of Bmi‑1 in U87 cells exposed to different doses of radiation was evaluated by western blot analysis. X‑ray radiation was found to inhibit U87 cell proliferation through the induction of senescence rather than apoptosis. Following exposure to radiation, the cell cycle distribution was dysregulated, with an increased number of cells in the G2/M phase, and the expression of Bmi‑1 was upregulated, particularly when a dose of ≥6 Gy was administered. The results indicated that senescence is the main mechanism by which U87 cell growth is inhibited following radiation. In addition, Bmi‑1 may be significant in increasing the radioresistance of glioma cells by enabling cell senescence.

View Figures

View References

1	Louis DN, Ohgaki H, Wiestler OD, et al: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 114:97–109. 2007.
2	Ohgaki H, Dessen P, Jourde B, et al: Genetic pathways to glioblastoma: a population-based study. Cancer Res. 64:6892–6899. 2004.
3	Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 455:1061–1068. 2008.
4	Ohgaki H and Kleihues P: Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Sci. 100:2235–2241. 2009.
5	Lee JJ, Kim BC, Park MJ, et al: PTEN status switches cell fate between premature senescence and apoptosis in glioma exposed to ionizing radiation. Cell Death Differ. 18:666–677. 2011.
6	Quick QA and Gewirtz DA: An accelerated senescence response to radiation in wild-type p53 glioblastoma multiforme cells. J Neurosurg. 105:111–118. 2006.
7	Nam HY, Han MW, Chang HW, et al: Radioresistant cancer cells can be conditioned to enter senescence by mTOR inhibition. Cancer Res. 73:4267–4277. 2013.
8	Hwang ES, Yoon G and Kang HT: A comparative analysis of the cell biology of senescence and aging. Cell Mol Life Sci. 66:2503–2524. 2009.
9	Chowdhury M, Mihara K, Yasunaga S, Ohtaki M, Takihara Y and Kimura A: Expression of Polycomb-group (PcG) protein BMI-1 predicts prognosis in patients with acute myeloid leukemia. Leukemia. 21:1116–1122. 2007.
10	Vonlanthen S, Heighway J, Altermatt HJ, et al: The Bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression. Br J Cancer. 84:1372–1376. 2001.
11	Zhang FB, Sui LH and Xin T: Correlation of Bmi-1 expression and telomerase activity in human ovarian cancer. Br J Biomed Sci. 65:172–177. 2008.
12	Song LB, Li J, Liao WT, et al: The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. J Clin Invest. 119:3626–3636. 2009.
13	Guo BH, Feng Y, Zhang R, et al: Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer. Mol Cancer. 10:102011.
14	Dhawan S, Tschen SI and Bhushan A: Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation. Genes Dev. 23:906–911. 2009.
15	Bruggeman SW, Hulsman D, Tanger E, et al: Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Cancer Cell. 12:328–341. 2007.
16	Glinsky GV, Berezovska O and Glinskii AB: Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer. J Clin Invest. 115:1503–1521. 2005.
17	Häyry V, Tynninen O, Haapasalo HK, et al: Stem cell protein BMI-1 is an independent marker for poor prognosis in oligodendroglial tumours. Neuropathol Appl Neurobiol. 34:555–563. 2008.
18	Li J, Gong LY, Song LB, et al: Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB pathway. Am J Pathol. 176:699–709. 2010.
19	Taylor LP: Diagnosis, treatment, and prognosis of glioma: five new things. Neurology. 75:S28–S32. 2010.
20	Stupp R, Mason WP, van den Bent MJ, et al; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996. 2005.
21	Clarke J, Butowski N and Chang S: Recent advances in therapy for glioblastoma. Arch Neurol. 67:279–283. 2010.
22	Stupp R, Hegi ME, Mason WP, et al; European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. Lancet Oncol. 10:459–466. 2009.
23	Xie C, Wang H, Cheng H, Li J, Wang Z and Yue W: RAD18 mediates resistance to ionizing radiation in human glioma cells. Biochem Biophys Res Commun. 445:263–268. 2014.
24	Liu P, Huang Z, Chen Z, et al: Silver nanoparticles: a novel radiation sensitizer for glioma? Nanoscale. 5:11829–11836. 2013.
25	Naidu MD, Mason JM, Pica RV, Fung H and Peña LA: Radiation resistance in glioma cells determined by DNA damage repair activity of Ape1/Ref-1. J Radiat Res. 51:393–404. 2010.
26	Jendrossek V: The intrinsic apoptosis pathways as a target in anticancer therapy. Curr Pharm Biotechnol. 13:1426–1438. 2012.
27	Dewey WC, Ling CC and Meyn RE: Radiation-induced apoptosis: relevance to radiotherapy. Int J Radiat Oncol Biol Phys. 33:781–796. 1995.
28	Schmitt CA: Cellular senescence and cancer treatment. Biochim Biophys Acta. 1775:5–20. 2007.
29	Roninson IB: Tumor cell senescence in cancer treatment. Cancer Res. 63:2705–2715. 2003.
30	Li Y, Hu J, Guan F, et al: Copper induces cellular senescence in human glioblastoma multiforme cells through downregulation of Bmi-1. Oncol Rep. 29:1805–1810. 2013.
31	Jacobs JJ, Kieboom K, Marino S, DePinho RA and van Lohuizen M: The oncogene and Polycomb-group gene Bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature. 397:164–168. 1999.
32	Jiang L, Li J and Song L: Bmi-1, stem cells and cancer. Acta Biochim Biophys Sin (Shanghai). 41:527–534. 2009.
33	Hara E, Smith R, Parry D, Tahara H, Stone S and Peters G: Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol Cell Biol. 16:859–867. 1996.
34	Molofsky AV, Pardal R, Iwashita T, Park IK, Clarke MF and Morrison SJ: Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature. 425:962–967. 2003.